Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Calls
Puts
Net calls
Funds Holding
2,284
Funds Holding Change
+8
Funds Holding Growth
+0.4%
Value
$760B
Holding in Top 10
1,005
Top 10 Change
-43
Top 10 Growth
-4%
Value Growth
+6%
New
82
Increased
929
Reduced
1,125
Closed
52
Capital Inflow
$22.5B
Capital Outflow
$28.5B
Net Capital Flow
-$5.94B
Capital Flow Change
-$728B
Calls
$7.97B
Puts
$9.04B
Net Calls
-$1.07B
Put/Call Ratio
1.13